Background The efficacy of vaginal progesterone for preventing preterm birth and adverse
perinatal outcomes in singleton gestations with a short cervix has been questioned after …

Objective To evaluate the efficacy of vaginal progesterone administration for preventing
preterm birth and perinatal morbidity and mortality in asymptomatic women with a singleton …

ISUOG Practice Guidelines: role of ultrasound in the prediction of spontaneous preterm birth
ISUOG Practice Guidelines: role of ultrasound in the prediction of spontaneous preterm birth …

Background An indirect comparison meta-analysis published in 2013 reported that both
vaginal progesterone and cerclage are equally efficacious for preventing preterm birth and …

Preterm birth, defined as birth occurring prior to 37 weeks gestation, is a serious obstetric
problem accounting for 11% of pregnancies worldwide. It is associated with significant …

Progestogens (vaginal progesterone and intramuscular 17‐hydroxyprogesterone acetate)
are widely recommended for women at high risk of preterm birth. Typical regimens include …

Background A comprehensive preterm birth prevention program was introduced in the state
of Western Australia encompassing new clinical guidelines, an outreach program for health …

Obstetrical & Gynecological Survey Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

The PREGNANT trial was a randomized, placebo-controlled, multicenter trial designed to
determine the efficacy and safety of vaginal progesterone (VP) to reduce the risk of birth< 33 …

Despite an increasing body of knowledge on the adverse clinical sequelae associated with
late preterm birth and early term birth, little is known about their economic consequences or …